Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease

Clinical trial NCT00948259 · COMPLETED

Trial details

NCT number: NCT00948259
Sponsor: Noscira SA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer´s Disease

Start date: 2008-12-01
Primary completion: 2009-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.